MedPath
HSA Approval

URACTONUM TABLET 25 mg

SIN00664P

URACTONUM TABLET 25 mg

URACTONUM TABLET 25 mg

May 3, 1988

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C03DA01

spironolactone

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE LTD

Active Ingredients

SPIRONOLACTONE

25 mg

Spironolactone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

URACTONUM TABLET 25 mg - HSA Approval | MedPath